| Dr Dmitriy Vaysman, MD | |
|
655 Deer Park Ave, Babylon, NY 11702-1314 | |
| (631) 321-2100 | |
| (631) 321-2246 |
| Full Name | Dr Dmitriy Vaysman |
|---|---|
| Gender | Male |
| Speciality | Pediatric Medicine |
| Experience | 30 Years |
| Location | 655 Deer Park Ave, Babylon, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245231232 | NPI | - | NPPES |
| 02753455 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2080P0214X | Pediatrics - Pediatric Pulmonology | 221613 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Good Samaritan Hospital Medical Center | West islip, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Samaritan Pediatric Services Pc | 7618151887 | 9 |
News Archive
Alexion Pharma International Sàrl, a subsidiary of Alexion Pharmaceuticals, Inc., today announced that the U.S. Food and Drug Administration has granted a Breakthrough Therapy designation to cyclic pyranopterin monophosphate (cPMP, or ALXN1101), an enzyme co-factor replacement therapy for the treatment of patients with molybdenum cofactor deficiency type A, a severe and life-threatening, ultra-rare, genetic metabolic disorder that causes catastrophic and irreversible neurologic damage within the first weeks of life.
Anecdotal evidence suggests that the hypothalamus, a structure lying deep within the brain may be involved in generating laughter. Gelastic epilepsy, a rare condition characterized by laughing seizures, is commonly the result of a congenital brain lesion within the hypothalamus.
As the COVID-19 pandemic continues to spread, new and unusual chronic sequelae of the disease are cropping up in many medical practices. Now, a new case paper published in The Lancet in September 2020 describes a case of new-onset Parkinson's disease following infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
The economic downturn is contributing to a decline in overall family health in the Hispanic community, with parents prioritizing their children's health over their own. While 44 percent of Hispanics consider it equally important for parents to take care of their own health and the health of their children, significantly more parents say the economic downturn has affected their own health and wellness compared to that of their children (69 percent vs. 59 percent).
› Verified 5 days ago
| Entity Name | Wyckoff Professional Medical Services Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659710796 PECOS PAC ID: 6406748607 Enrollment ID: O20040324001805 |
News Archive
Alexion Pharma International Sàrl, a subsidiary of Alexion Pharmaceuticals, Inc., today announced that the U.S. Food and Drug Administration has granted a Breakthrough Therapy designation to cyclic pyranopterin monophosphate (cPMP, or ALXN1101), an enzyme co-factor replacement therapy for the treatment of patients with molybdenum cofactor deficiency type A, a severe and life-threatening, ultra-rare, genetic metabolic disorder that causes catastrophic and irreversible neurologic damage within the first weeks of life.
Anecdotal evidence suggests that the hypothalamus, a structure lying deep within the brain may be involved in generating laughter. Gelastic epilepsy, a rare condition characterized by laughing seizures, is commonly the result of a congenital brain lesion within the hypothalamus.
As the COVID-19 pandemic continues to spread, new and unusual chronic sequelae of the disease are cropping up in many medical practices. Now, a new case paper published in The Lancet in September 2020 describes a case of new-onset Parkinson's disease following infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
The economic downturn is contributing to a decline in overall family health in the Hispanic community, with parents prioritizing their children's health over their own. While 44 percent of Hispanics consider it equally important for parents to take care of their own health and the health of their children, significantly more parents say the economic downturn has affected their own health and wellness compared to that of their children (69 percent vs. 59 percent).
› Verified 5 days ago
| Entity Name | Samaritan Pediatric Services Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730308925 PECOS PAC ID: 7618151887 Enrollment ID: O20110413000020 |
News Archive
Alexion Pharma International Sàrl, a subsidiary of Alexion Pharmaceuticals, Inc., today announced that the U.S. Food and Drug Administration has granted a Breakthrough Therapy designation to cyclic pyranopterin monophosphate (cPMP, or ALXN1101), an enzyme co-factor replacement therapy for the treatment of patients with molybdenum cofactor deficiency type A, a severe and life-threatening, ultra-rare, genetic metabolic disorder that causes catastrophic and irreversible neurologic damage within the first weeks of life.
Anecdotal evidence suggests that the hypothalamus, a structure lying deep within the brain may be involved in generating laughter. Gelastic epilepsy, a rare condition characterized by laughing seizures, is commonly the result of a congenital brain lesion within the hypothalamus.
As the COVID-19 pandemic continues to spread, new and unusual chronic sequelae of the disease are cropping up in many medical practices. Now, a new case paper published in The Lancet in September 2020 describes a case of new-onset Parkinson's disease following infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
The economic downturn is contributing to a decline in overall family health in the Hispanic community, with parents prioritizing their children's health over their own. While 44 percent of Hispanics consider it equally important for parents to take care of their own health and the health of their children, significantly more parents say the economic downturn has affected their own health and wellness compared to that of their children (69 percent vs. 59 percent).
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Dmitriy Vaysman, MD 655 Deer Park Ave, Babylon, NY 11702-1314 Ph: (631) 321-2100 | Dr Dmitriy Vaysman, MD 655 Deer Park Ave, Babylon, NY 11702-1314 Ph: (631) 321-2100 |
News Archive
Alexion Pharma International Sàrl, a subsidiary of Alexion Pharmaceuticals, Inc., today announced that the U.S. Food and Drug Administration has granted a Breakthrough Therapy designation to cyclic pyranopterin monophosphate (cPMP, or ALXN1101), an enzyme co-factor replacement therapy for the treatment of patients with molybdenum cofactor deficiency type A, a severe and life-threatening, ultra-rare, genetic metabolic disorder that causes catastrophic and irreversible neurologic damage within the first weeks of life.
Anecdotal evidence suggests that the hypothalamus, a structure lying deep within the brain may be involved in generating laughter. Gelastic epilepsy, a rare condition characterized by laughing seizures, is commonly the result of a congenital brain lesion within the hypothalamus.
As the COVID-19 pandemic continues to spread, new and unusual chronic sequelae of the disease are cropping up in many medical practices. Now, a new case paper published in The Lancet in September 2020 describes a case of new-onset Parkinson's disease following infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
The economic downturn is contributing to a decline in overall family health in the Hispanic community, with parents prioritizing their children's health over their own. While 44 percent of Hispanics consider it equally important for parents to take care of their own health and the health of their children, significantly more parents say the economic downturn has affected their own health and wellness compared to that of their children (69 percent vs. 59 percent).
› Verified 5 days ago
Marion B Rose, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 500 W Main St, Suite 204, Babylon, NY 11702 Phone: 631-539-5400 Fax: 631-539-5401 | |
Edward H Tom, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 50 N Carll Ave, Babylon, NY 11702 Phone: 631-661-3693 Fax: 631-661-3734 | |
Dr. Sarita Duchatelier, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 655 Deer Park Ave, Babylon, NY 11702 Phone: 631-321-2100 Fax: 631-321-2246 | |
Rohit Talwar, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 500 West Main Street, Nslij Center For Specialty Care, Suite 204, Babylon, NY 11702 Phone: 631-539-5400 Fax: 631-539-5401 | |
Michael T Pugliese, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 655 Deer Park Ave, Babylon, NY 11702 Phone: 631-321-2100 Fax: 631-321-2246 | |
Eleonor Gutierrez Lazo, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 400 West Main Street, Suite 328, Babylon, NY 11702 Phone: 631-376-1002 Fax: 631-376-1004 |